drugset / Trial / NCT00567086
Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the effects of a single sc administration of TEZAMPANEL at one of three different dosage levels compared to placebo, employing traditional measures of efficacy and safety in the treatment of a single episode of acute migraine.
Timeline
- Start
- 2006-10
- Primary completion
- —
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TEZAMPANEL ANHYDROUS | Small molecule | 40 mg | Subcutaneous |
| Subject | TEZAMPANEL ANHYDROUS | Small molecule | 70 mg | Subcutaneous |
| Subject | TEZAMPANEL ANHYDROUS | Small molecule | 100 mg | Subcutaneous |